{"transactions":[{"id":692744,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25338,"kind":"person","name":"Galitzer Hillel","position":1,"cik":"0001904740","reported_name":"Galitzer Hillel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-07T20:19:53.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents a grant of options to purchase ordinary shares. This grant of options was approved by the Board of Directors (the \"Board\") of Entera Bio Ltd. (the \"Company\") on May 7, 2026, subject to the filing by the Company of a Registration Statement on Form S-8 registering the ordinary shares underlying the option grant, which occurred on August 7, 2026. The options vest over a three year period which began on May 7, 2026, with one third of the options vesting on May 7, 2027 and the remaining two-thirds vesting ratably on a quarterly basis over the remaining two-year period, subject to full acceleration upon a Change in Control (as defined in the Company's 2018 Equity Incentive Plan)."}],"balance_after":200000,"derivative":{"exercise_price":1.37,"expiration_date":"2036-05-07","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001178913-26-003952","document":"zk2635794.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891326003952/zk2635794.xml","form_type":"4"}},{"id":786232,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25338,"kind":"person","name":"Galitzer Hillel","position":1,"cik":"0001904740","reported_name":"Galitzer Hillel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2026-05-08T20:29:12.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":72993,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board of Directors (the \"Board\") of Entera Bio Ltd. (the \"Company\") on May 7, 2026. This grant was awarded to the Reporting Person in lieu of a cash bonus the Reported Person was otherwise entitled to. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on May 1, 2026."}],"balance_after":163566,"source":{"system":"sec-edgar","filing":"0001178913-26-002466","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891326002466/ownership.xml","form_type":"4"}},{"id":1163228,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25338,"kind":"person","name":"Galitzer Hillel","position":1,"cik":"0001904740","reported_name":"Galitzer Hillel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-30T20:22:04.000Z","date":"2025-04-28","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest over a three-year period with 33% of the options vesting on April 28, 2025, the first anniversary of the vesting commencement date, and the remaining options vesting ratably on a quarterly basis over the remaining three-year period."}],"balance_after":100000,"derivative":{"exercise_price":2.28,"expiration_date":"2025-04-28","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001178913-25-001539","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891325001539/ownership.xml","form_type":"4"}},{"id":1163227,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25338,"kind":"person","name":"Galitzer Hillel","position":1,"cik":"0001904740","reported_name":"Galitzer Hillel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2025-04-30T20:22:04.000Z","date":"2025-04-28","kind":"grant","planned":false,"acquired":true,"shares":26316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of stock-settled restricted stock units. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 28, 2025."}],"balance_after":90573,"source":{"system":"sec-edgar","filing":"0001178913-25-001539","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891325001539/ownership.xml","form_type":"4"}},{"id":1536698,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25338,"kind":"person","name":"Galitzer Hillel","position":1,"cik":"0001904740","reported_name":"Galitzer Hillel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-23T21:30:35.000Z","date":"2024-04-19","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest over a three-year period with 33% of the options vesting on April 19, 2025, the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining two-year period."}],"balance_after":130000,"derivative":{"exercise_price":1.99,"expiration_date":"2034-04-19","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001178913-24-001421","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891324001421/ownership.xml","form_type":"4"}},{"id":1536697,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25338,"kind":"person","name":"Galitzer Hillel","position":1,"cik":"0001904740","reported_name":"Galitzer Hillel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Ordinary Shares, par value NIS 0.0000769 per share","published_at":"2024-04-23T21:30:35.000Z","date":"2024-04-19","kind":"grant","planned":false,"acquired":true,"shares":30151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represent a grant of stock-settled restricted stock units. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on April 19, 2024."}],"balance_after":64257,"source":{"system":"sec-edgar","filing":"0001178913-24-001421","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891324001421/ownership.xml","form_type":"4"}},{"id":1913949,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25338,"kind":"person","name":"Galitzer Hillel","position":1,"cik":"0001904740","reported_name":"Galitzer Hillel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-25T21:20:32.000Z","date":"2023-04-24","kind":"grant","planned":false,"acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a four-year period with 25% of the options vesting on April 24, 2024, the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period."}],"balance_after":210000,"derivative":{"exercise_price":0.795,"expiration_date":"2033-04-24","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001178913-23-001530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891323001530/ownership.xml","form_type":"4"}},{"id":2307118,"issuer":{"id":5464,"kind":"organization","name":"Entera Bio Ltd."},"owners":[{"id":25338,"kind":"person","name":"Galitzer Hillel","position":1,"cik":"0001904740","reported_name":"Galitzer Hillel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-04-04T20:05:58.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a four-year period that commenced on March 31, 2022, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period."}],"balance_after":60000,"derivative":{"exercise_price":2.86,"expiration_date":"2032-03-31","underlying":"Ordinary Shares, par value NIS 0.0000769 per share","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001178913-22-001387","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638097/000117891322001387/ownership.xml","form_type":"4"}}]}